Hamps Bio Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

4.36

1.96

1.50

1.50

1.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

4.44

1.41

-0.49

-0.58

-0.36

Loan funds

Secured loans

2.97

1.05

2.04

2.44

2.65

Unsecured loans

-

-

-

-

-

Total

11.77

4.42

3.05

3.36

3.29

Uses of funds

Fixed assets

Gross block

5.05

4.72

3.72

4.26

3.65

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

2.57

2.15

1.56

1.24

1.05

Net block

2.48

2.56

2.15

3.02

2.61

Capital work-in-progress

3.38

-

-

-

-

Investments

-

-

0.04

-

0.01

Net current assets

Current assets, loans & advances

6.93

2.58

1.45

1.61

1.60

Less : current liabilities & provisions

1.03

0.73

0.59

1.28

0.93

Total net current assets

5.90

1.85

0.86

0.33

0.68

Miscellaneous expenses not written

-

-

-

-

-

Total

11.77

4.42

3.05

3.36

3.29

Notes:

Book value of unquoted investments

-

-

0.04

-

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

43.56

19.60

15.00

15.00

10.00